Risk Perception in Drug-Dependent Adults With and Without Schizophrenia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-08-18

Study Completion Date

2012-05-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background:

* Several studies of risk perception have demonstrated a common bias known as unrealistic optimism, in which individuals feel they are less likely than other people to experience unpleasant or harmful events in their lives, but more likely to experience pleasant or beneficial events.
* Previous research has indicated that individuals with schizophrenia have less of a sense of unrealistic optimism about adverse events than individuals without schizophrenia. However, research on risk perception in schizophrenia is sparse, primarily reporting on behaviors and decisions in the laboratory that likely are influenced by risk perception.
* Risk perception among substance users may be viewed in two separate categories: perception of vulnerability to adverse events and perception of vulnerability to negative outcomes associated with substance use. Research in both areas has yielded mixed results. Researchers are interested in studying the connections among schizophrenia, addiction, and risk perception in order to develop better drug use prevention and treatment programs for people with and without schizophrenia.

Objectives:

\- To compare unrealistic optimism bias in people with and without schizophrenia and/or drug dependence, and its association with actual risky behavior.

Eligibility:

* Individuals between 18 and 64 years of age who fall into one of the following study categories:
* diagnoses of both drug dependence (marijuana or cocaine) and schizophrenia/schizoaffective disorder
* diagnosis of drug dependence only (marijuana or cocaine)
* diagnosis of schizophrenia/schizoaffective disorder only
* healthy volunteers with no history of drug use or serious mental disorder

Design:

* The study will require a single visit to the research center for a 5- to 6-hour session.
* Participants will complete questionnaires on medical and behavioral history, complete tests of thinking skills like memory and attention, complete a brief computerized decision-making task, and answer questions about risk perception.
* Participants will also provide urine samples and breath carbon monoxide measurements to test for recent use of tobacco and other substances.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Influence of Nicotine on Cognitive Function in Schizophrenic Patients With and Without Comorbid Drug Dependence

NCT01037075

Schizophrenia Drug Abuse/Dependency

COMPLETED

Knowledge and Perception of Smoking Risks/Consequences

NCT00686101

Cigarette Smoking Schizophrenia

COMPLETED

Dopamine Function and Reward Processing In Schizophrenia

NCT01035996

Schizophrenia

COMPLETED

Effects of Nicotine on Areas of Impaired and Preserved Functioning in Schizophrenia

NCT01034085

Nicotine Dependence Schizophrenia

COMPLETED

Predictors of Treatment Outcome for Smokers With and Without Schizophrenia

NCT00501007

Tobacco Dependence

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background:

Several studies of risk perception have demonstrated a common bias known as unrealistic optimism', in which individuals feel they are less likely than other people to experience unpleasant or harmful events in their lives, but more likely to experience pleasant or beneficial events. In a previous study, we showed that unrealistic optimism about adverse events in patients with schizophrenia was lower than in healthy controls.

Objective:

To compare unrealistic optimism bias in people with and without schizophrenia and/or drug dependence, and its association with actual risky behavior.

Study Population:

Adults with current diagnosis (DSM-IV criteria) of schizophrenia or schizoaffective disorder (n = 24), with current drug dependence (cannabis or cocaine) (n = 24), with both schizophrenia and drug dependence (n = 24), or healthy, non-drug-using controls (n = 24).

Study Design:

Subjects will have a single study visit, at which their psychiatric and substance use histories, current substance use (urine drug testing, expired breath CO), risk perception, risk-taking/impulsivity, sensation-seeking, insight, history of risky behavior, and cognitive function will be assessed.

Outcome Measures:

Scores on Risk Perception Questionnaire, Balloon Analog Risk Task, short form self-report assessments of risk perception, risk-taking/impulsivity and sensation-seeking, Revised Life Orientation Scale, Self-Mastery Scale, Zuckerman-Kuhlman Personality Questionnaire, Repeatable Battery for the Assessment of Neuropsychological Status. South Oaks Gambling Screen-Revised, NORC DSM-IV Screen for Gambling Problems.

Benefit:

There is no direct benefit to subjects from study participation. Future benefits to society might be better understanding of risk perception biases associated with co-occurring substance abuse and schizophrenia, leading to development of more effective prevention and treatment programs and improved processes for obtaining informed consent.

Risks:

This study poses minimal risk to subjects, primarily boredom or anxiety from taking questionnaires and psychological tests and embarrassment from giving an observed urine specimen for drug testing.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cocaine Dependence Cannabis Dependence Schizophrenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Exclusion Criteria

1. Group 1: Drug dependence with schizophrenia or schizoaffective disorder

Inclusion: Drug dependence; schizophrenia or schizoaffective disorder

Exclusions: mood disorder; obsessive-compulsive disorder (OCD)
2. Group 2: Drug dependence without schizophrenia or schizoaffective disorder

Inclusion: Drug dependence.

Exclusions: schizophrenia or schizoaffective disorder; mood disorder; OCD.
3. Group 3: Schizophrenia or schizoaffective disorder without drug dependence

Inclusion: DSM-IV schizophrenia or schizoaffective disorder.

Exclusions: mood disorder; OCD; use of illegal drugs more than 3 times in the previous month.
4. Group 4: Healthy comparison participants

Exclusions: Any DSM-IV Axis I diagnosis (except simple phobia); use of illegal drugs more than 3 times in the previous month.
5. Exclusions for all groups: History of neurological disease/condition (unrelated to schizophrenia or drug dependence) with ongoing cognitive sequelae; physical limitations (e.g., with hearing, vision or movement) that would prevent performance of computerized tasks; documented mental retardation.
6. Substances of choice among drug-dependent participants (Groups 1 and 2) must be marijuana, cocaine or both (the commonest illegal drugs of abuse among patients with schizophrenia).

Minimum Eligible Age

18 Years

Maximum Eligible Age

64 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No